Xiaju Cheng

2.2k total citations · 2 hit papers
43 papers, 1.8k citations indexed

About

Xiaju Cheng is a scholar working on Biomedical Engineering, Molecular Biology and Immunology. According to data from OpenAlex, Xiaju Cheng has authored 43 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Biomedical Engineering, 17 papers in Molecular Biology and 16 papers in Immunology. Recurrent topics in Xiaju Cheng's work include Nanoplatforms for cancer theranostics (28 papers), Immunotherapy and Immune Responses (9 papers) and Photoacoustic and Ultrasonic Imaging (7 papers). Xiaju Cheng is often cited by papers focused on Nanoplatforms for cancer theranostics (28 papers), Immunotherapy and Immune Responses (9 papers) and Photoacoustic and Ultrasonic Imaging (7 papers). Xiaju Cheng collaborates with scholars based in China, Italy and Australia. Xiaju Cheng's co-authors include Zhifang Chai, Haibin Shi, Mingyuan Gao, Rui Sun, Cuicui Ge, Ling Yin, Yuliang Zhao, Yuan Yong, Wenyan Yin and Mian Zu and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and The EMBO Journal.

In The Last Decade

Xiaju Cheng

39 papers receiving 1.8k citations

Hit Papers

Light‐Triggered Assembly of Gold Nanoparticles for Photot... 2015 2026 2018 2022 2016 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaju Cheng China 18 1.3k 699 574 544 276 43 1.8k
Shao‐Kai Sun China 24 1.5k 1.2× 1.3k 1.8× 535 0.9× 466 0.9× 164 0.6× 81 2.5k
Kai Cheng China 27 1.5k 1.2× 847 1.2× 562 1.0× 546 1.0× 119 0.4× 72 2.2k
Yuxia Tang China 26 1.6k 1.3× 1.0k 1.5× 833 1.5× 594 1.1× 195 0.7× 59 2.4k
Xuehua Ma China 23 1.1k 0.9× 743 1.1× 622 1.1× 474 0.9× 327 1.2× 59 1.9k
Maoquan Chu China 24 1.3k 1.0× 959 1.4× 685 1.2× 401 0.7× 239 0.9× 63 2.1k
Yushen Jin China 24 1.6k 1.2× 641 0.9× 800 1.4× 477 0.9× 261 0.9× 46 2.1k
Lijia Jing China 19 1.3k 1.0× 633 0.9× 617 1.1× 491 0.9× 175 0.6× 37 1.7k
Ajlan Al Zaki United States 14 1.1k 0.9× 537 0.8× 989 1.7× 595 1.1× 177 0.6× 17 2.0k
Wei Yin China 23 1000 0.8× 512 0.7× 623 1.1× 332 0.6× 284 1.0× 61 1.8k
Yinchu Ma China 24 1.6k 1.3× 812 1.2× 605 1.1× 634 1.2× 123 0.4× 34 2.2k

Countries citing papers authored by Xiaju Cheng

Since Specialization
Citations

This map shows the geographic impact of Xiaju Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaju Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaju Cheng more than expected).

Fields of papers citing papers by Xiaju Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaju Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaju Cheng. The network helps show where Xiaju Cheng may publish in the future.

Co-authorship network of co-authors of Xiaju Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaju Cheng. A scholar is included among the top collaborators of Xiaju Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaju Cheng. Xiaju Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Qian, et al.. (2025). Nano-strategies for Targeting Tumor-Associated Macrophages in Cancer immunotherapy. Journal of Cancer. 16(7). 2261–2274. 1 indexed citations
2.
Cheng, Xiaju, et al.. (2025). Chemical Construction of In Situ Tumor Vaccination. ACS Nano. 19(26). 23517–23538.
3.
Li, Liubing, Yanxian Wu, Xiaju Cheng, et al.. (2025). Hyaluronic acid and polyvinyl alcohol-based radioresponsive hydrogel for combined radioimmunotherapy of breast cancer bone metastasis. Carbohydrate Polymers. 368(Pt 1). 124108–124108. 1 indexed citations
4.
Li, Miao, Yirui Guo, Yuqi Zhang, et al.. (2025). Engineering TLR7/8 Agonist‐Loaded and Tumor‐Anchored Gold Nanosensitizers for Enhanced Radioimmunotherapy. Small. 21(33). e2503133–e2503133. 1 indexed citations
5.
Wu, Yanxian, Chenze Li, Jiahao Shen, et al.. (2024). Mechanotransduction-Piloted Whole-Cell Vaccines for Spatiotemporal Modulation of Postoperative Antitumor Immunity. ACS Nano. 18(42). 28675–28690. 4 indexed citations
6.
Yu, Huan, et al.. (2024). Mechanoimmune-Driven Backpack Sustains Dendritic Cell Maturation for Synergistic Tumor Radiotherapy. ACS Nano. 18(34). 23741–23756. 10 indexed citations
7.
Wu, Yanxian, et al.. (2024). Tumor Metabolism Aiming Cu2–xS Nanoagents Mediate Photothermal-Derived Cuproptosis and Immune Activation. ACS Nano. 18(35). 23941–23957. 25 indexed citations
8.
Xu, Pei, Chenze Li, Xiaju Cheng, et al.. (2024). Radioactive Hydroxyapatite Microspheres Empower Sustainable In Situ Tumor Vaccination. ACS Nano. 18(28). 18425–18443. 7 indexed citations
10.
Li, Xiangrong, Facai Zhang, Ying Kong, et al.. (2024). Acetylation of TIR domains in the TLR4-Mal-MyD88 complex regulates immune responses in sepsis. The EMBO Journal. 43(21). 4954–4983. 17 indexed citations
11.
Wu, Yanxian, Can Chen, Wei-Zhi Song, et al.. (2024). Tailored modulation of reactive oxygen species and anti-inflammatory responses in periodontitis using in situ diselenium-crosslinked chitosan hydrogel. Nano Today. 61. 102588–102588. 3 indexed citations
12.
Cheng, Xiaju, Jiahao Shen, Jingwei Xu, et al.. (2023). In vivo clinical molecular imaging of T cell activity. Trends in Immunology. 44(12). 1031–1045. 8 indexed citations
13.
Afshari, Mohammad Javad, Xiaju Cheng, Guangxin Duan, et al.. (2023). Vision for Ratiometric Nanoprobes: In Vivo Noninvasive Visualization and Readout of Physiological Hallmarks. ACS Nano. 17(8). 7109–7134. 13 indexed citations
14.
Wu, Yanxian, Xiaju Cheng, Leshuai W. Zhang, et al.. (2023). Harnessing astaxanthin-loaded diselenium cross-linked apotransferrin nanoparticles for the treatment of secretory otitis media. Journal of Controlled Release. 365. 398–411. 5 indexed citations
15.
Xia, Huawei, Anna Wang, Qiulian Mao, et al.. (2023). Light-initiated aggregation of gold nanoparticles for synergistic chemo-photothermal tumor therapy. Nanoscale Advances. 5(11). 3053–3062. 13 indexed citations
16.
Gu, Yuan, Yanxian Wu, Pei Xu, et al.. (2023). Targeting STING Activation by Antigen‐Inspired MnO2 Nanovaccines Optimizes Tumor Radiotherapy. Advanced Healthcare Materials. 12(12). e2300028–e2300028. 34 indexed citations
17.
Xu, Pei, Jie Ma, Yang Zhou, et al.. (2023). Radiotherapy-Triggered In Situ Tumor Vaccination Boosts Checkpoint Blockaded Immune Response via Antigen-Capturing Nanoadjuvants. ACS Nano. 18(1). 1022–1040. 22 indexed citations
18.
Li, Xiangrong, Xiaju Cheng, Jia Sun, et al.. (2021). Acetylation-dependent glutamate receptor GluR signalosome formation for STAT3 activation in both transcriptional and metabolism regulation. Cell Death Discovery. 7(1). 11–11. 10 indexed citations
19.
Cheng, Xiaju, Yuan Yong, Yiheng Dai, et al.. (2017). Enhanced Radiotherapy using Bismuth Sulfide Nanoagents Combined with Photo-thermal Treatment. Theranostics. 7(17). 4087–4098. 90 indexed citations
20.
Deng, Yaoyao, Xiaju Cheng, Jing Zhu, et al.. (2016). Facile preparation of hybrid core–shell nanorods for photothermal and radiation combined therapy. Nanoscale. 8(7). 3895–3899. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026